Contact Information:
Dr. Georgiev received his Ph.D. in Computer Science from Duke University, after which he served as a staff scientist and co-head of the Structural Bioinformatics Core Section at the Vaccine Research Center, NIH. Dr. Georgiev is currently an Associate Professor in the Departments of Pathology, Microbiology, and Immunology and of Computer Science at Vanderbilt. Since 2020, he has served as the Director of Graduate Studies for the Vanderbilt Program in Chemical and Physical Biology.
Dr. Georgiev is the founding Director of the Vanderbilt Program in Computational Microbiology and Immunology, a program focused on supporting research, educational, and strategic efforts that aim to employ the power of computation toward the development and application of innovative approaches for treatment and prevention of disease and for enhancement of human health. Dr. Georgiev has published more than 100 peer-reviewed manuscripts, including in top-tier journals such as Cell, Science, Nature, Nature Biotechnology, and others.
As a Principal Investigator, he has received substantial funding from the United States National Institutes of Health (NIH), as well as from private foundations and from industry. Dr. Georgiev’s research is focused on the development and application of technologies related to problems in the fields of immunology and microbiology, with a special emphasis on structure-based vaccine design and antibody discovery and optimization. In this program, Dr. Georgiev will contribute expertise at the nexus of immunobiology, virology, structural biology and computational biology, including mentorship, workshop, reviewer, and other training experiences, along with research efforts toward understanding antigen-specific antibody responses.